FDA Still Under Gun On Antibiotics, Despite Hopeful Signs

By Jeff Overley (July 11, 2013, 7:08 PM EDT) -- Antibiotic development is showing signs of life after years of hibernation, with multiple drugs becoming eligible for quicker approval and extra exclusivity in the year since Congress created those key incentives, but experts say the U.S. Food and Drug Administration still must eliminate regulatory hurdles to solve the crisis of obsolete antibacterials....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!